[go: up one dir, main page]

AR068374A1 - Nuevas composiciones farmaceuticas del complejo lamivudina beta - ciclodextrina - Google Patents

Nuevas composiciones farmaceuticas del complejo lamivudina beta - ciclodextrina

Info

Publication number
AR068374A1
AR068374A1 ARP080103870A ARP080103870A AR068374A1 AR 068374 A1 AR068374 A1 AR 068374A1 AR P080103870 A ARP080103870 A AR P080103870A AR P080103870 A ARP080103870 A AR P080103870A AR 068374 A1 AR068374 A1 AR 068374A1
Authority
AR
Argentina
Prior art keywords
pharmaceutical compositions
lamivudina
ciclodextrina
new pharmaceutical
beta complex
Prior art date
Application number
ARP080103870A
Other languages
English (en)
Inventor
Perez Sergio Lloret
Colomer Marina Puigvert
Original Assignee
Combino Pharm Sl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Combino Pharm Sl filed Critical Combino Pharm Sl
Publication of AR068374A1 publication Critical patent/AR068374A1/es

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nanotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invencion se refiere a nuevos complejos de lamivudina/ciclodextrina y a procedimientos para preparar dichos complejos. La presente invencion también se refiere a nuevas Composiciones farmacéuticas solidas que comprenden lamivudina, donde a lamivudina está presente en forma de dichos complejos de lamivudina/ciclodextrina. La presente invencion también se refiere a procedimientos para preparar dichas composiciones.
ARP080103870A 2007-09-06 2008-09-05 Nuevas composiciones farmaceuticas del complejo lamivudina beta - ciclodextrina AR068374A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US96761207P 2007-09-06 2007-09-06

Publications (1)

Publication Number Publication Date
AR068374A1 true AR068374A1 (es) 2009-11-11

Family

ID=40342715

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP080103870A AR068374A1 (es) 2007-09-06 2008-09-05 Nuevas composiciones farmaceuticas del complejo lamivudina beta - ciclodextrina

Country Status (3)

Country Link
US (1) US20090068267A1 (es)
AR (1) AR068374A1 (es)
WO (1) WO2009031026A2 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8481554B2 (en) 2009-05-27 2013-07-09 Hetero Research Foundation Solid oral dosage forms of lamivudine
EP2953945A2 (en) * 2013-02-07 2015-12-16 Tobira Therapeutics, Inc. Lamivudine salts

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9111902D0 (en) * 1991-06-03 1991-07-24 Glaxo Group Ltd Chemical compounds
WO2001085218A2 (en) * 2000-05-11 2001-11-15 Eastman Chemical Company Acylated cyclodextrin guest inclusion complexes
WO2005112637A1 (en) * 2004-05-14 2005-12-01 Decode Chemistry, Inc. Formulations for non-parenteral use including hydrophobic cyclodextrins
WO2007009265A1 (en) * 2005-07-22 2007-01-25 The Governors Of The University Of Alberta Tec Edmonton NOVEL β-CYCLODEXTRIN-BASED MOLECULES AND DRUG DELIVERY COMPOSITIONS

Also Published As

Publication number Publication date
WO2009031026A2 (en) 2009-03-12
US20090068267A1 (en) 2009-03-12
WO2009031026A3 (en) 2009-11-05

Similar Documents

Publication Publication Date Title
BR112012028291A2 (pt) composições farmacêuticas e métodos para sua produção
HN2011001810A (es) Sintesis de espirikpiridinas radiomarcadas con 18f a partir de precursores de tosilato y composiciones farmaceuticas estables de estas.
DOP2012000038A (es) Conjugados de dímeros de pirrolo [1,4] benzodiazepina como agentes anticancerosos
MX2018008597A (es) Composiciones inyectables de melfalan que comprenden un derivado de ciclodextrina y metodos de fabricacion y uso de las mismas.
BR112013007362A2 (pt) composição farmacêutica
UY31484A1 (es) Piperidinas heteroaril-sustituidas
GT201200250A (es) Ariltriazolonas ligadas a bisarilo y su uso
PA8660301A1 (es) Pirazolo piridinas sustituidas, composiciones que las contienen, procedimiento de fabricacion y utilizacion
EP2688425A4 (en) GLUCOSYLATED STEVIOL GLYCOSIDE COMPOSITION AS A TASTING MODIFYING AGENT
BRPI1013426A2 (pt) organismos para produção de 1,3-butanodiol
MX375715B (es) Profarmacos de metilfenidato, procesos de elaboración y uso de los mismos.
CL2012003491A1 (es) Compuesto derivado de dihidropirrol sustituidos; proceso para preparar dichos derivados en forma estereoselectiva.
UY32052A (es) 5-aminopirazoles sustituidos y uso de los mismos
CR11078A (es) Una composicion de liberacion prolongada que comprende un derivado de somatostatina en microparticulas
BR112012000398A2 (pt) processo para preparação de uma partícula de perfume.
CR20110208A (es) Proceso para la preparación de benzonorbornenos
HN2011003102A (es) Piperidinas sustituidas
AR068374A1 (es) Nuevas composiciones farmaceuticas del complejo lamivudina beta - ciclodextrina
CR9211A (es) Composiciones que comprenden una epotilona y metodos de produccion
BR112012008952A2 (pt) microbicidas
PA8661601A1 (es) Pirroles sustituidos, composiciones que los contienen, proceso de fabricacion y utilizacion
BR112013030842A2 (pt) composição, processo para a produção de poliamidas de fundição e uso da composição
CL2011000932A1 (es) Proceso para la preparacion de 9-diclorometilen-1,2,3,3-tetrahidro-1,4-metano-naftalen-5-ilamina; compuesto intermedio y proceso para preparar 6,6-diclorfulveno.
TWD139386S1 (zh) 汽車用之頭燈
AR068977A1 (es) Procedimiento para la preparacion de pentahidroxihexilcarbamoilundecanoato de bencilo y compuesto intermediario utilizado en la fabricacion del mismo

Legal Events

Date Code Title Description
FB Suspension of granting procedure